the assessment of the inflammatory changes in abdominal aortic aneurysm by Pioglitazone

the assessment of the inflammatory changes in abdominal aortic aneurysm by Pioglitazone - AIC test

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003009

Enrollment

100

Registered

2010-01-10

Start date

2009-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal aortic aneurysm, arteriosclerosis obliterans

Interventions

pioglitazone 25 cases statin 25cases ARB 25 cases non-treated 25ceses

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who agreed this study

Exclusion criteria

Exclusion criteria: 1,the patients who did not agree this study 2,infective aneurysm

Design outcomes

Primary

Measure	Time frame
hsCRP, FACS analysis of Inflammatory cells, Inflammatory Cytokine analysis, RT-PCR analysis (Adiponectin, Leptin, TNF-alpha,IL-1beta,MCP-1, PAI-1, IL-8, IL-6, Resistin, Angiotensinogen, VEGF, MMP)	—

Secondary

Measure	Time frame
blood examination 75g OGTT	—

Countries

Japan

Contacts

Public ContactHirotsugu KUROBE

IHBS, the university of TOKUSHIMA Graduate of School Cardiovascular surgery

hp@tokushima-cvs.info088-633-7408

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026